Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$3,521,964
+$2,010,446 QoQ
Shares Held
146,261
+171.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#743
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Koshinski Asset Management, Inc. holds $47,150,309 across 10 Drug Manufacturers - General names. PFE ranks #4 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
84,147 | $21,370,813 | |
| 2 | ABBV |
AbbVie Inc.
|
34,655 | $8,720,584 | |
| 3 | LLY |
ELI LILLY & Co
|
5,099 | $6,115,894 | |
| 4 | PFE |
Pfizer Inc
This page
|
146,261 | $3,521,964 | |
| 5 | AMGN |
Amgen Inc
|
9,577 | $3,468,023 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
21,669 | $1,248,567 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,983 | $1,008,572 | |
| 8 | AZN |
Astrazeneca PLC
|
4,741 | $898,988 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,521,964 | 146,261 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,511,518 | 53,829 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $995,651 | 39,986 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $847,057 | 33,244 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $750,858 | 30,976 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $588,090 | 23,208 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $562,780 | 21,213 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $694,617 | 24,002 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $664,133 | 23,736 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $673,353 | 24,265 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $579,686 | 20,135 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $950,386 | 28,652 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,079,382 | 29,427 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,753,543 | 42,979 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $2,526,490 | 49,307 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $2,232,197 | 51,010 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,734,172 | 52,149 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $3,047,855 | 58,873 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $3,458,440 | 58,568 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $2,350,797 | 54,657 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,350,589 | 34,489 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,569,954 | 43,333 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,364,141 | 37,059 | Shares | Sole | 2021-03-30 | |
| 2020-09-30 | $1,130,285 | 30,798 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $929,661 | 28,430 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $777,516 | 23,821 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||